Published in Trials on November 07, 2008
HPTN 071 (PopART): a cluster-randomized trial of the population impact of an HIV combination prevention intervention including universal testing and treatment: mathematical model. PLoS One (2014) 1.66
Performance characteristics of the Cepheid Xpert MTB/RIF test in a tuberculosis prevalence survey. PLoS One (2012) 1.53
Validation of brief screening tools for depressive and alcohol use disorders among TB and HIV patients in primary care in Zambia. BMC Psychiatry (2011) 1.47
Annual risk of tuberculous infection using different methods in communities with a high prevalence of TB and HIV in Zambia and South Africa. PLoS One (2009) 1.32
Is passive diagnosis enough? The impact of subclinical disease on diagnostic strategies for tuberculosis. Am J Respir Crit Care Med (2012) 1.31
Can combination prevention strategies reduce HIV transmission in generalized epidemic settings in Africa? The HPTN 071 (PopART) study plan in South Africa and Zambia. J Acquir Immune Defic Syndr (2013) 1.23
Risk factors associated with positive QuantiFERON-TB Gold In-Tube and tuberculin skin tests results in Zambia and South Africa. PLoS One (2011) 1.15
High prevalence of tuberculosis and insufficient case detection in two communities in the Western Cape, South Africa. PLoS One (2013) 1.01
Age- and Sex-Specific Social Contact Patterns and Incidence of Mycobacterium tuberculosis Infection. Am J Epidemiol (2015) 1.00
Coital frequency and condom use in monogamous and concurrent sexual relationships in Cape Town, South Africa. J Int AIDS Soc (2013) 0.91
Comparison of indoor contact time data in Zambia and Western Cape, South Africa suggests targeting of interventions to reduce Mycobacterium tuberculosis transmission should be informed by local data. BMC Infect Dis (2016) 0.91
Field comparison of OraQuick ADVANCE Rapid HIV-1/2 antibody test and two blood-based rapid HIV antibody tests in Zambia. BMC Infect Dis (2012) 0.88
Household contact investigation for tuberculosis in Vietnam: study protocol for a cluster randomized controlled trial. Trials (2013) 0.81
The Impact and Cost-Effectiveness of a Four-Month Regimen for First-Line Treatment of Active Tuberculosis in South Africa. PLoS One (2015) 0.77
Intra-Cluster Correlation Estimates for HIV-related Outcomes from Care and Treatment Clinics in Dar es Salaam, Tanzania. Contemp Clin Trials Commun (2016) 0.77
Diabetes mellitus in Zambia and the Western Cape province of South Africa: Prevalence, risk factors, diagnosis and management. Diabetes Res Clin Pract (2016) 0.77
Coverage of clinic-based TB screening in South Africa may be low in key risk groups. Public Health Action (2015) 0.75
Concurrent partnerships in Cape Town, South Africa: race and sex differences in prevalence and duration of overlap. J Int AIDS Soc (2015) 0.75
The association of hyperglycaemia with prevalent tuberculosis: a population-based cross-sectional study. BMC Infect Dis (2016) 0.75
School-based interventions to promote early diagnosis of TB: realising the promise of community-based screening? Public Health Action (2012) 0.75
BUTIMBA: Intensifying the Hunt for Child TB in Swaziland through Household Contact Tracing. PLoS One (2017) 0.75
Why test for tuberculosis? A qualitative study from South Africa. Public Health Action (2016) 0.75
Missed opportunities for retention in pre-ART care in Cape Town, South Africa. PLoS One (2014) 0.75
High burden of prevalent tuberculosis among previously treated people in Southern Africa suggests potential for targeted control interventions. Eur Respir J (2016) 0.75
Simple sample size calculation for cluster-randomized trials. Int J Epidemiol (1999) 10.46
Sexual behavior of HIV discordant couples after HIV counseling and testing. AIDS (2003) 8.05
Increase in high risk sexual behaviour among homosexual men, London 1996-8: cross sectional, questionnaire study. BMJ (2000) 4.51
Active case finding of tuberculosis: historical perspective and future prospects. Int J Tuberc Lung Dis (2005) 4.36
Analysis and reporting of factorial trials: a systematic review. JAMA (2003) 3.02
Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev (2004) 2.95
Design and analysis issues in cluster-randomized trials of interventions against infectious diseases. Stat Methods Med Res (2000) 2.36
Effectiveness of HIV prevention interventions in developing countries. AIDS (2000) 2.35
Development and evaluation of a new chest radiograph reading and recording system for epidemiological surveys of tuberculosis and lung disease. Int J Tuberc Lung Dis (2005) 2.23
HIV incidence during a cluster-randomized trial of two strategies providing voluntary counselling and testing at the workplace, Zimbabwe. AIDS (2007) 2.15
Design, analysis and presentation of factorial randomised controlled trials. BMC Med Res Methodol (2003) 2.10
Covariate-based constrained randomization of group-randomized trials. Clin Trials (2004) 2.03
Guidelines for conducting tuberculin skin test surveys in high prevalence countries. Tuber Lung Dis (1996) 1.70
Recommendations of the Interim Policy on Collaborative TB/HIV activities. Wkly Epidemiol Rec (2004) 1.33
Can we control tuberculosis in high HIV prevalence settings? Tuberculosis (Edinb) (2003) 1.29
Restricted randomization of ZAMSTAR: a 2 x 2 factorial cluster randomized trial. Clin Trials (2008) 1.22
Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS (2006) 10.56
Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis (2009) 6.96
Patients with active tuberculosis often have different strains in the same sputum specimen. Am J Respir Crit Care Med (2003) 5.22
Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. Am J Respir Crit Care Med (2005) 4.94
Evaluation of respondent-driven sampling. Epidemiology (2012) 4.75
Effect of household and community interventions on the burden of tuberculosis in southern Africa: the ZAMSTAR community-randomised trial. Lancet (2013) 4.58
The Millennium Development Goals: a cross-sectoral analysis and principles for goal setting after 2015 Lancet and London International Development Centre Commission. Lancet (2010) 4.24
Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010. Bull World Health Organ (2011) 4.19
Transmission of HIV-1 infection in sub-Saharan Africa and effect of elimination of unsafe injections. Lancet (2004) 4.13
Male circumcision for HIV prevention: from evidence to action? AIDS (2008) 4.11
A trial of mass isoniazid preventive therapy for tuberculosis control. N Engl J Med (2014) 4.07
Reinfection and mixed infection cause changing Mycobacterium tuberculosis drug-resistance patterns. Am J Respir Crit Care Med (2005) 3.75
Proportion of tuberculosis transmission that takes place in households in a high-incidence area. Lancet (2004) 3.65
Biological and behavioural impact of an adolescent sexual health intervention in Tanzania: a community-randomized trial. AIDS (2007) 3.51
How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners. J Infect Dis (2004) 3.50
Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS (2002) 3.47
Human immunodeficiency virus and the prevalence of undiagnosed tuberculosis in African gold miners. Am J Respir Crit Care Med (2004) 3.26
The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children. Vaccine (2006) 3.16
Epidemiology of tuberculosis in a high HIV prevalence population provided with enhanced diagnosis of symptomatic disease. PLoS Med (2007) 2.88
Stability of variable-number tandem repeats of mycobacterial interspersed repetitive units from 12 loci in serial isolates of Mycobacterium tuberculosis. J Clin Microbiol (2002) 2.77
Uptake of workplace HIV counselling and testing: a cluster-randomised trial in Zimbabwe. PLoS Med (2006) 2.71
Gene-expression patterns in whole blood identify subjects at risk for recurrent tuberculosis. J Infect Dis (2006) 2.68
Childhood pulmonary tuberculosis: old wisdom and new challenges. Am J Respir Crit Care Med (2006) 2.68
HIV-1/AIDS and the control of other infectious diseases in Africa. Lancet (2002) 2.64
Transmission of tuberculosis in a high incidence urban community in South Africa. Int J Epidemiol (2004) 2.62
Morbidity and mortality in South African gold miners: impact of untreated disease due to human immunodeficiency virus. Clin Infect Dis (2002) 2.60
Performance of commercially available enzyme immunoassays for detection of antibodies against herpes simplex virus type 2 in African populations. J Clin Microbiol (2004) 2.55
Male circumcision for HIV prevention in sub-Saharan Africa: who, what and when? AIDS (2008) 2.54
Risk factors for house-entry by malaria vectors in a rural town and satellite villages in The Gambia. Malar J (2008) 2.51
Prevalence of tuberculosis, HIV and respiratory symptoms in two Zambian communities: implications for tuberculosis control in the era of HIV. PLoS One (2009) 2.42
A four-month gatifloxacin-containing regimen for treating tuberculosis. N Engl J Med (2014) 2.39
Use of light-emitting diode fluorescence microscopy to detect acid-fast bacilli in sputum. Clin Infect Dis (2008) 2.38
Isoniazid preventive therapy and risk for resistant tuberculosis. Emerg Infect Dis (2006) 2.29
A refined symptom-based approach to diagnose pulmonary tuberculosis in children. Pediatrics (2006) 2.21
HIV incidence during a cluster-randomized trial of two strategies providing voluntary counselling and testing at the workplace, Zimbabwe. AIDS (2007) 2.15
Long-term biological and behavioural impact of an adolescent sexual health intervention in Tanzania: follow-up survey of the community-based MEMA kwa Vijana Trial. PLoS Med (2010) 2.09
HIV infection does not affect active case finding of tuberculosis in South African gold miners. Am J Respir Crit Care Med (2009) 2.07
Provider-initiated symptom screening for tuberculosis in Zimbabwe: diagnostic value and the effect of HIV status. Bull World Health Organ (2010) 2.03
Effects of genetic variability of Mycobacterium tuberculosis strains on the presentation of disease. Lancet Infect Dis (2005) 1.93
Empirical observations underestimate the proportion of human immunodeficiency virus infections attributable to sexually transmitted diseases in the Mwanza and Rakai sexually transmitted disease treatment trials: Simulation results. Sex Transm Dis (2006) 1.91
Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysis. PLoS Med (2011) 1.89
Multiple Mycobacterium tuberculosis strains in early cultures from patients in a high-incidence community setting. J Clin Microbiol (2002) 1.88
Exploring the potential impact of a reduction in partnership concurrency on HIV incidence in rural Uganda: a modeling study. Sex Transm Dis (2012) 1.83
Trends in the prevalence and management of diagnosed type 2 diabetes 1994-2001 in England and Wales. BMC Fam Pract (2005) 1.80
Evaluation of young children in contact with adult multidrug-resistant pulmonary tuberculosis: a 30-month follow-up. Pediatrics (2002) 1.74
Persisting with prevention: the importance of adherence for HIV prevention. Emerg Themes Epidemiol (2008) 1.71
The Regai Dzive Shiri Project: a cluster randomised controlled trial to determine the effectiveness of a multi-component community-based HIV prevention intervention for rural youth in Zimbabwe--study design and baseline results. Trop Med Int Health (2008) 1.70
Default during TB diagnosis: quantifying the problem. Trop Med Int Health (2009) 1.69
Risk factors for herpes simplex virus type 2 and HIV among women at high risk in northwestern Tanzania: preparing for an HSV-2 intervention trial. J Acquir Immune Defic Syndr (2007) 1.69
Tuberculin skin test and in vitro assays provide complementary measures of antimycobacterial immunity in children and adolescents. Chest (2009) 1.68
Long-term impact of acyclovir suppressive therapy on genital and plasma HIV RNA in Tanzanian women: a randomized controlled trial. J Infect Dis (2010) 1.67
High prevalence of tuberculosis in previously treated patients, Cape Town, South Africa. Emerg Infect Dis (2007) 1.65
Can population differences explain the contrasting results of the Mwanza, Rakai, and Masaka HIV/sexually transmitted disease intervention trials?: A modeling study. J Acquir Immune Defic Syndr (2004) 1.65
Asking semi-literate adolescents about sexual behaviour: the validity of assisted self-completion questionnaire (ASCQ) data in rural Tanzania. Trop Med Int Health (2004) 1.65
Lives saved by tuberculosis control and prospects for achieving the 2015 global target for reducing tuberculosis mortality. Bull World Health Organ (2011) 1.64
Higher risk behaviour and rates of sexually transmitted diseases in Mwanza compared to Uganda may help explain HIV prevention trial outcomes. AIDS (2003) 1.63
Retrospective cohort study of false alarm rates associated with a series of heart operations: the case for hospital mortality monitoring groups. BMJ (2004) 1.62
Understanding the differences between contrasting HIV epidemics in east and west Africa: results from a simulation model of the Four Cities Study. Sex Transm Infect (2007) 1.60
Association of schistosomiasis with false-positive HIV test results in an African adolescent population. J Clin Microbiol (2010) 1.59
Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy? AIDS (2003) 1.51
A proposed radiological classification of childhood intra-thoracic tuberculosis. Pediatr Radiol (2004) 1.50
Assessing tuberculosis case fatality ratio: a meta-analysis. PLoS One (2011) 1.49
Cervicovaginal HIV-1 and herpes simplex virus type 2 shedding during genital ulcer disease episodes. AIDS (2007) 1.48
Treating curable sexually transmitted infections to prevent HIV in Africa: still an effective control strategy? J Acquir Immune Defic Syndr (2008) 1.48
The effects of HIV on the sensitivity of a whole blood IFN-gamma release assay in Zambian adults with active tuberculosis. PLoS One (2008) 1.48
No decrease in annual risk of tuberculosis infection in endemic area in Cape Town, South Africa. Trop Med Int Health (2009) 1.47
The Regai Dzive Shiri project: results of a randomized trial of an HIV prevention intervention for youth. AIDS (2010) 1.47
Farming with your hoe in a sack: condom attitudes, access, and use in rural Tanzania. Stud Fam Plann (2006) 1.46
How you ask really matters: randomised comparison of four sexual behaviour questionnaire delivery modes in Zimbabwean youth. Sex Transm Infect (2010) 1.45
Microbicides development program, Tanzania-baseline characteristics of an occupational cohort and reattendance at 3 months. Sex Transm Dis (2007) 1.39
Combination prevention: new hope for stopping the epidemic. Curr HIV/AIDS Rep (2013) 1.36
Resistant Mycobacterium bovis Bacillus Calmette-Guérin disease: implications for management of Bacillus Calmette-Guérin Disease in human immunodeficiency virus-infected children. Pediatr Infect Dis J (2004) 1.36
Stable incidence rates of tuberculosis (TB) among human immunodeficiency virus (HIV)-negative South African gold miners during a decade of epidemic HIV-associated TB. J Infect Dis (2003) 1.36
Annual risk of tuberculous infection using different methods in communities with a high prevalence of TB and HIV in Zambia and South Africa. PLoS One (2009) 1.32
Costs of measures to control tuberculosis/HIV in public primary care facilities in Cape Town, South Africa. Bull World Health Organ (2006) 1.32
Immunosuppression during active tuberculosis is characterized by decreased interferon- gamma production and CD25 expression with elevated forkhead box P3, transforming growth factor- beta , and interleukin-4 mRNA levels. J Infect Dis (2007) 1.30
Patient care seeking barriers and tuberculosis programme reform: a qualitative study. Health Policy (2004) 1.29
Childhood drug-resistant tuberculosis in the Western Cape Province of South Africa. Acta Paediatr (2006) 1.29
Adult-type pulmonary tuberculosis in children 10-14 years of age. Pediatr Infect Dis J (2005) 1.29
Beijing and Haarlem genotypes are overrepresented among children with drug-resistant tuberculosis in the Western Cape Province of South Africa. J Clin Microbiol (2006) 1.28
Association of genital shedding of herpes simplex virus type 2 and HIV-1 among sex workers in rural Zimbabwe. AIDS (2006) 1.27
Can combination prevention strategies reduce HIV transmission in generalized epidemic settings in Africa? The HPTN 071 (PopART) study plan in South Africa and Zambia. J Acquir Immune Defic Syndr (2013) 1.23
Overview of effective and promising interventions to prevent HIV infection. World Health Organ Tech Rep Ser (2006) 1.23
Operational challenges in managing Isoniazid Preventive Therapy in child contacts: a high-burden setting perspective. BMC Public Health (2011) 1.22
A qualitative study of HPV vaccine acceptability among health workers, teachers, parents, female pupils, and religious leaders in northwest Tanzania. Vaccine (2012) 1.22